GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Abstract Text:

Jung-Jun Park,Jason R Berggren,Matthew W Hulver,Joseph A Houmard,Eric P Hoffman,

Obesity is associated with insulin resistance in skeletal muscle; accordingly, weight loss dramatically improves insulin action. We sought to identify molecular remodeling of muscle commensurate with weight loss that could explain improvements in insulin action. Muscle from morbidly obese women was studied before and after gastric bypass surgery. Gastric bypass surgery significantly reduced body mass by approximately 45% and improved insulin action. We then assessed mRNA profiles using a stringent statistical analysis (statistical concordance with three probe set algorithms), with validation in a cross-sectional study of lean (n = 8) vs. morbidly obese (n = 8) muscle. Growth factor receptor-bound protein 14 (GRB14), glycerol-3-phosphate dehydrogenase 1 (GPD1), and growth differentiation factor 8 (GDF8; myostatin) significantly decreased approximately 2.4-, 2.2-, and 2.4-fold, respectively, after weight loss (gastric bypass). Increased expression of these transcripts was associated with increased obesity in the cross-sectional group (lean vs. morbidly obese muscle). Each transcript was validated by real-time quantitative RT-PCR assays in both study groups. Using Ingenuity Pathway Analysis, we show that all three transcripts are involved in the same regulatory network including AKT1, IGF1, TNF, PPARG, and INS. These results suggest that GRB14, GPD1, and GDF8 are weight loss-responsive genes in skeletal muscle and that the observed transcriptional modulation of these would be expected to improve insulin signaling, decrease triglyceride synthesis, and increase muscle mass, respectively, with weight loss. Thus our data provide a possible regulatory pathway involved in the development of insulin resistance in the morbidly obese state, and improvement of insulin resistance with weight loss.

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Publishing Authors By Initials

JJ Park,JR Berggren,MW Hulver,JA Houmard,EP Hoffman,

For similar pathological conditions, signs and symptoms: signs and symptoms: body weight: body weight changes: weight loss research abstracts see: pathological conditions, signs and symptoms: signs and symptoms: body weight: body weight changes: weight loss research

PUBMED ID PMID:

MEDLINE DATE:

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Journal Published:

PUBLICATION TYPE: Validation Studies

Journal: Physiological genomics

VOLUME: 27

Page Numbers: 114-21

Journal Abbreviation: Physiol. Genomics

ISSN: 1531-2267

DAY: 18

MONTH: 07

YEAR: 2006

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9815683

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Keywords Mesh Terms:

KEYWORDS: Weight Loss

MESH TERMS: physiology

Chemical & Substance for Abstract: GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Information

Substance Name: Glycerol-3-Phosphate Dehydrogenase (NAD+

Registry Number: EC 1.1.1.8

Grant and Affiliation Information for GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.

AFFILIATION: Research Center for Genetic Medicine, Children's National Medical Center, Washington, District of Columbia 20010, USA.

Country: United States

AGENCY: United States NICHD

GRANT: 5U10HD030447

ACRONYM: HD

MEDLINETA: Physiol Genomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle Related Publications

• Anti-inflammatory drug delivery from hyaluronic acid hydrogels.
• Bone morphogenetic protein-2 induces scar formation and skin maturation in the second trimester fetus.
• Characteristics of airflow in a CT-based ovine lung: a numerical study.
• Chemotherapy targets the hair-follicle vascular network but not the stem cells.
• Comparing the electronic properties of the low-spin cyano-ferric [Fe(N4)(Cys)] active sites of superoxide reductase and p450cam using ENDOR spectroscopy and DFT calculations.
• Connecting nitrogenase intermediates with the kinetic scheme for N2 reduction by a relaxation protocol and identification of the N2 binding state.
• Demonstration by 2H ENDOR spectroscopy that myo-inositol binds via an alkoxide bridge to the mixed-valent diiron center of myo-inositol oxygenase.
• Dynamic docking of cytochrome b5 with myoglobin and alpha-hemoglobin: heme-neutralization "squares" and the binding of electron-transfer-reactive configurations.
• EPR study of the low-spin [d(3); S =(1)/(2)], Jahn-Teller-active, dinitrogen complex of a molybdenum trisamidoamine.
• Effect of intoxication among blunt trauma patients selected for head computed tomography scanning.
• Effect of low-xenon and krypton supplementation on signal/noise of regional CT-based ventilation measurements.
• Examining histone acetlylation at specific genomic regions.
• GFP-expressing vascularization of Gelfoam as a rapid in vivo assay of angiogenesis stimulators and inhibitors.
• GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.
• Hemangiomas and homeobox gene expression.
• How an enzyme tames reactive intermediates: positioning of the active-site components of lysine 2,3-aminomutase during enzymatic turnover as determined by ENDOR spectroscopy.
• In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
• Mean length of utterance in children with specific language impairment and in younger control children shows concurrent validity and stable and parallel growth trajectories.
• Midline anterior craniofacial approach for malignancy: results of en bloc versus piecemeal resections.
• NMR spectroscopy can characterize proteins encapsulated in a sol-gel matrix.
• Prevention and treatment of vivax malaria.
• Rapid freeze-quench ENDOR study of chloroperoxidase compound I: the site of the radical.
• Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.
• Regional pulmonary blood flow in dogs by 4D-X-ray CT.
• Risk factors for asthma among cosmetology professionals in Colorado.
• Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
• Surface-associated hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model.
• Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer.
• The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
• Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice.